rhinoplasty.cc
Menu

Journal archive · Ethnic, Asian, Middle Eastern, African and Latino rhinoplasty · Non-surgical and filler rhinoplasty · Anatomy and nasal analysis · 2016

ASJ Aesthetic Surgery Journal · 2016

Efficacy and Safety of a Hyaluronic Acid Filler to Correct Aesthetically Detracting or Deficient Features of the Asian Nose: A Prospective, Open-Label, Long-Term Study

Liew S, Scamp T, de Maio M, Halstead M, Johnston N, Silberberg M, Rogers JD.

In the archive as a landmark paper: the core sweep runs 2011–2026, and this one is here because the history of rhinoplasty rests on it · cited on injection rhinoplasty.

Abstract

Background: There is increasing interest among patients and plastic surgeons for alternatives to rhinoplasty, a common surgical procedure performed in Asia.

Objectives: To evaluate the safety, efficacy, and longevity of a hyaluronic acid filler in the correction of aesthetically detracting or deficient features of the Asian nose.

Methods: Twenty-nine carefully screened Asian patients had their noses corrected with the study filler (Juvéderm VOLUMA [Allergan plc, Dublin, Ireland] with lidocaine injectable gel), reflecting individualized treatment goals and utilizing a standardized injection procedure, and were followed for over 12 months.

Results: A clinically meaningful correction (≥1 grade improvement on the Assessment of Aesthetic Improvement Scale) was achieved in 27 (93.1%) patients at the first follow-up visit. This was maintained in 28 (96.6%) patients at the final visit, based on the independent assessments of a central non-injecting physician and the patients. At this final visit, 23 (79.3%) patients were satisfied or very satisfied with the study filler and 25 (86.2%) would recommend it to others. In this small series of patients, there were no serious adverse events (AEs), with all treatment-related AEs being mild to moderate, transient injection site reactions, unrelated to the study filler.

Conclusions: Using specific eligibility criteria, individualized treatment goals, and a standardized injection procedure, the study filler corrected aesthetically detracting or deficient features of the Asian nose, with the therapeutic effects lasting for over 12 months, consistent with a high degree of patient satisfaction. This study supports the safety and efficacy of this HA filler for specific nose augmentation procedures in selected Asian patients. LEVEL OF EVIDENCE 3: Therapeutic.

Abstract as indexed by PubMed; the article is open access (PubMed Central).

Citation

PubMed
Journal
Aesthetic Surgery Journal
Year
2016
Authors
7
Type
Journal Article
Access
Open access
On this site
Full abstract

Start here

What the rhinoplasty literature says on this paper's topics, cited line by line to PubMed.

Related papers

Same topic, 2016.

  1. ASJ
    2016PMID 27277274Summary
  2. ASJ
    2016PMID 27535924
  3. ASJ
    2016PMID 27095313Full text
  4. ASJ
    2016PMID 26764261Summary
  5. ASJ
    2016PMID 26063834Summary
  6. ASJ
    2016PMID 26773090Summary
  7. ASJ
    2016PMID 26879296Summary
  8. APS
    2016PMID 27752742Abstract